Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-05-03
2008-08-19
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S277000, C514S311000, C514S364000, C514S406000, C544S232000, C546S256000, C546S138000, C548S131000, C548S152000, C548S247000, C548S364100
Reexamination Certificate
active
07414056
ABSTRACT:
The present invention provides pyrazole derived compounds of formula (I)useful for treating p38 kinase-associated conditions, where G, X, R1, R2, R3, R4, R5, R6and m are as defined herein. The invention further pertains to pharmaceutical compositions containing at least one compound according to the invention useful for treating p38 kinase-associated conditions, and methods of inhibiting the activity of p38 kinase in a mammal.
REFERENCES:
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6821965 (2004-11-01), Brown et al.
patent: 2002/0065270 (2002-05-01), Moriarty et al.
patent: 2002/0137747 (2002-09-01), Moriarty et al.
patent: 2003/0139435 (2003-07-01), Ahmed et al.
patent: 2005/0176965 (2005-08-01), Chen et al.
patent: 2006/0004067 (2006-01-01), Chen et al.
patent: 2006/0069132 (2006-03-01), Armel et al.
patent: 1 102 743 (2002-07-01), None
patent: WO 01/46172 (2001-06-01), None
patent: WO 02/062804 (2002-08-01), None
patent: WO2004/035545 (2004-04-01), None
patent: WO2004/071440 (2004-08-01), None
patent: WO2004/098518 (2004-11-01), None
patent: WO2004/099156 (2004-11-01), None
patent: WO2004/106324 (2004-12-01), None
patent: WO2005/042537 (2005-05-01), None
patent: WO2005/061465 (2005-07-01), None
patent: WO2005/077945 (2005-08-01), None
patent: WO2007/002742 (2007-01-01), None
Cheng, C.C. et al., “Potential Purine Antagonists. VI. Synthesis of 1-Alkyl- and 1-Aryl-4-substituted Pyrazolo[3,4-d]pyrimidines”, J. Org. Chem., vol. 21, pp. 1240-1256 (1956).
Deshayes, C. et al., “Synthesis of some Substituted 3-Alkenyl-1-phenylpyrazoles”, J. Heterocyclic Chem., vol. 16, pp. 657-660 (1979).
Greene, T.W. et al., Protective Groups in Organic Synthesis, Third Edition, John Wiley & Sons, Inc., publ., pp. xi-xii (table of contents) (1999).
Henry, J.R. et al., “p38 mitogen-activated protein kinase as a target for drug discovery”, Drugs of the Future, vol. 24, No. 12, pp. 1345-1354 (1999).
Iwata, S. et al., “Synthesis of (Trifluoromethyl)pyrazoles via 1,3-Dipolar Cycloaddition Reaction and Their Derivation to Photochromic Fulgides”, Nippon Kagaku Kaishi, vol. 10, pp. 1144-1147 (1992) (with English abstract).
Joule, J.A. et al., Chapter 22: “1,2-Azoles: pyrazoles, isothiazoles and isoxazoles: reactions and synthesis”, Heterocyclic Chemistry, Third Edition, Stanley Thornes (Publishers) Ltd., publ., pp. 394-408 (1995).
Manferdini, M. et al., “Chemoselective Synthesis of Pyrazole Derivatives via β-Enamino Keto Esters”, Heterocycles, vol. 53, No. 12, pp. 2775-2780 (2000).
Manning, G. et al., “The Protein Kinase Complement of the Human Genome”, Science, vol. 298, pp. 1912-1916, 1933-1934 (2002).
Moreland, L.W. et al., “Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial”, Ann. Intern. Med., vol. 130, No. 6, pp. 478-486 (1999).
Rankin, E.C.C. et al., “The Therapeutic Effects of an Engineered Human Anti-Tumour Necrosis Factor Alpha Antibody (CDP571) in Rheumatoid Arthritis”, British Journal of Rheumatology, vol. 34, No. 4, pp. 334-342 (1995).
Salituro, F.G. et al., “Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases”, Current Medicinal Chemistry, vol. 6, No. 9, pp. 807-823 (1999).
Schlosser, M. et al., “Switchable Reactivity: The Site-Selective Functionalization of Trifluoromethyl-Substituted Pyrazoles”, Eur. J. Org. Chem., vol. 17, pp. 2913-2920 (2002).
Vicentini, C.B. et al., “A New Synthetic Entry to 3-Carboxamido-4-carboxylic Acid Derivatives of Isoxazole and Pyrazole”, J. Heterocyclic Chem., vol. 37, pp. 175-180 (2000).
Das Jagabandhu
Dyckman Alaric J.
Leftheris Katerina
Liu Chunjian
Moquin Robert V.
Bristol--Myers Squibb Company
Duncan Laurelee A.
Miano Rosemary A.
Sackey Ebenezer
Wilson James O.
LandOfFree
Pyrazole-amide compounds useful as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole-amide compounds useful as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole-amide compounds useful as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4008365